Progress in using magnetic fields to target tumors

Oct 19, 2012

(Phys.org)—Since the advent of cancer nanotechnology, researchers have sought to use magnetic fields to increase the concentration of drug-loaded iron oxide nanoparticles that reach a tumor. However, magnetic fields drop off quickly with distance, making it almost impossible to consider such an approach for tumors located more than a few centimeters from the skin. To solve what appears to be a fundamentally unsolvable problem, researchers at the Stanford University Center of Cancer Nanotechnology Excellence (Stanford CCNE) have taken a two-pronged approach, one that uses an external magnetic field and an implantable magnetizable mesh to create local magnetic fields strong enough to trap nanoparticles at a specific location.

Sanjiv Gambhir and Shan Wang led the research team that developed this new approach to magnetic targeting. The team reported its findings in the journal ACS Nano. Drs. Gambhir and Wang are the co- of the Stanford CCNE.

To boost the strength of the magnetic field near a tumor, the investigators used a commercially available micromesh made of nickel. When implanted close to tumors growing in mice, the mesh developed strong magnetic field gradients when a was placed next to the animal. These gradients were sufficient to capture large numbers of biocompatible magnetic iron oxide nanoparticles that the researchers injected into the animals.

The idea driving this work is that such a mesh could be implanted near a tumor in a procedure that would be far less invasive than tumor-removing surgery. The patient could then be treated with carrying large doses of antitumor drug. Such a procedure could also be useful in cases where surgical is not feasible.

In one set of experiments, the investigators dosed tumor-bearing animals with an iron oxide nanoparticle coated with a molecule known to block angiogenesis, the growth of new blood vessels that tumors require to grow and spread. While the nanoparticles alone caused tumors to shrink, when administered along with magnetic field trapping, the rate of tumor shrinkage increased dramatically. The investigators noted that effect of generating a localized magnetic field in the vicinity of the tumor was similar to that seen when they doubled the dose of anti-angiogenic nanoparticles without additional magnetization.

Explore further: Researchers improve how a peptide can be delivered to the diseased heart tissue of mice via nanotechnology

More information: "Fluorescent magnetic nanoparticles for magnetically enhanced cancer imaging and targeting in living subjects." ACS Nano. dx.doi.org/10.1021/nn301670a

Related Stories

Magnetic field directs nanoparticles to tumors

Nov 25, 2010

(PhysOrg.com) -- To improve the tumor-specific delivery of drug to tumors, a team of investigators from the University of California, San Diego (UCSD) has created a system of nanoparticles-within-a-nanoparticle that can be ...

New Nanoparticle Structure Boosts Magnetic Properties

Dec 19, 2005

Magnetic nanoparticles have shown promise as contrast-enhancing agents for improving cancer detection using magnetic resonance imaging (MRI), as miniaturized heaters capable of killing malignant cells, and as targeted drug ...

Tracking therapeutic nanoparticles that target breast tumors

Dec 17, 2010

Researchers at Rice University, collaborating with investigators at the Baylor College of Medicine, have used two different types of imaging technologies to track the delivery of a therapeutic nanoparticle to breast tumors. ...

Remote Magnetic Field Triggers Nanoparticle Drug Release

Nov 08, 2007

Magnetic nanoparticles heated by a remote magnetic field have the potential to release multiple anticancer drugs on demand at the site of a tumor, according to a study published in the journal Advanced Materials. Moreover, say th ...

Recommended for you

Nanosafety research: The quest for the gold standard

Oct 29, 2014

Empa toxicologist Harald Krug has lambasted his colleagues in the journal Angewandte Chemie. He evaluated several thousand studies on the risks associated with nanoparticles and discovered no end of shortc ...

New nanodevice to improve cancer treatment monitoring

Oct 27, 2014

In less than a minute, a miniature device developed at the University of Montreal can measure a patient's blood for methotrexate, a commonly used but potentially toxic cancer drug. Just as accurate and ten ...

User comments : 0

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.